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Abstract
SEMA3F, isolated from a 3p21.3 deletion, has antitumor
activity in transfected cells, and protein expression
correlates with tumor stage and histology. In primary
tumors, SEMA3F and VEGF surface staining is inversely
correlated. Coupled with SEMA3F at the leading edge of
motile cells, we previously suggested that both proteins
competitively regulate cell motility and adhesion. We
have investigated this using the breast cancer cell line,
MCF7. SEMA3F inhibited cell attachment and spreading
as evidenced by loss of lamellipodia extensions,
membrane ruffling, and cell–cell contacts, with cells
eventually rounding-up and detaching. In contrast,
VEGF had opposite effects. Although SEMA3F binds
NRP2 with 10- fold greater affinity than NRP1, the effects
in MCF7 were mediated by NRP1. This was determined
by receptor expression and blocking of anti -NRP1
antibodies. Similar effects, but through NRP2, were
observed in the C100 breast cancer cell line. Although
we were unable to demonstrate changes in total GTP-
bound Rac1 or RhoA, we did observe changes in the
localization of Rac1-GFP using time lapse microscopy.
Following SEMA3F, Rac1 moved to the base of lamelli-
podia and — with their collapse — to the membrane.
These results support the concept that SEMA3F and
VEGF have antagonistic actions affecting motility in
primary tumor cell.
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Introduction
Semaphorins are a large family of secreted, transmem-
brane- and membrane-associated proteins containing a
conserved, cystine-rich, 500-amino-acid Sema domain [1].
SEMA3A (Collapsin), as well as SEMA3F and other class 3
semaphorins (SEMA3B, C, D and E), are secreted proteins
containing an immunoglobulin - type domain. Originally iden-
tified as repulsive molecules for nerve growth cones [2], their
widespread expression suggested that they had additional
functions outside the nervous system. This was confirmed by
a SEMA3A knockout mouse that resulted in abnormal deve-
lopment of somite-derived and visceral tissues, in addition to
neural abnormalities [3,4].
SEMA3F was originally isolated from a recurrent 3p21.3
homozygous deletion in small cell lung cancer cell lines,
suggesting that it might be a tumor-suppressor gene [5–7].
Similarly, SEMA3B was also identified from the same 3p21.3
deletion [6]. In primary lung tumors, antibody staining against
SEMA3F was shown to correlate with both tumor stage and
histological subtype [8]. In a human lung cancer cell line
NCI-H1299, expressing predominantly NRP1, transfection of
SEMA3B and — to a lesser extent — SEMA3F inhibited in
vitro colony formation [9]. SEMA3F also inhibited tumori-
genesis of A9 cells in a nudemousemodel [10]. Likewise, the
tumorigenicity of HEY ovarian adenocarcinoma cells was
inhibited by SEMA3B [11]. Thus, SEMA3F and SEMA3B
demonstrate clear antitumor effects as judged by correlations
with staging and by their effects in in vitro and in vivo model
systems.
The receptors for class 3 semaphorins are two related
proteins, neuropilin-1 (NRP1) and neuropilin -2 (NRP2)
[12,13]. In addition, NRP1 in endothelial cells is a coreceptor
for vascular endothelial growth factor VEGF165 [14], and
NRP2 binds VEGF165 and VEGF145 [15]. In endothelial cells,
SEMA3A blocks VEGF165- induced cell motility and lamelli-
podia formation [16]. In the nervous system, semaphorin
signaling involves homo- and heterodimers of NRP1/NRP2,
plexins, and small GTPases such as Rac1 ( for reviews, see
Refs. [17–21]). Other factors affecting SEMA3A signalling
include collapsin response mediator protein (CRMP) [22]
and the PDZ binding protein NIP [23]. In lung cancer cell lines
expressing varying levels of CRMP, their invasive potential
was inversely correlated with CRMP expression [24], a
finding which is consistent with antitumor effects of class 3
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semaphorins. At the cellular level, COS7 cells expressing
NRP1 and plexin-1 contract within 5 to 30 minutes of
SEMA3A exposure [25]. Similar effects were observed
with SEMA3F in COS7 cells expressing NRP2/plexin-1.
Other investigators have shown that exposure to sem-
aphorins results in rapid reorganization of actin filaments,
normally present in lamellipodia and filopodia [26].
Based on the inverse staining patterns of VEGF and
SEMA3F on primary lung cancer cells, SEMA3F staining at
the leading edge of motile cells [8 ], and the reported
antagonism between SEMA3A and VEGF in endothelial
cells, we suggested that VEGF and SEMA3F might
competitively regulate cell motility and adhesion in epithelial
cancers. We have studied this in two breast cancer cell lines,
MCF7 and C100, which differentially express NRP receptors.
We also identified changes in Rac1 localization following
exposure to SEMA3F. These results further strengthen the
concept that secreted semaphorins compete with VEGF for
effects on tumor cells themselves. Thus, the normal balance
between VEGF and semaphorins, which is frequently and
substantially disrupted in various epithelial cancers, may
have important consequences on migration as it does to
angiogenesis.
Materials and Methods
Plasmid Constructions
AP-SEMA3F was built by cloning SEMA3F cDNA into
pSecTagA vector ( Invitrogen, Cergy Pontoise, France) at
the 30 end of the alkaline phosphatase gene and was
generously provided by Dr. M. Tessier -Lavigne [13]. AP-
pSecTag (AP) expressed alkaline phosphatase as negative
control. Rac1-GFP was a gift from Dr. Fort (CRBM, Mont-
pellier, France).
Cell Lines and Transfections
The human mammary epithelial cell lines utilized were
MCF7 and C100, a derivative of MDA-MB-435S [27]. MCF7
cells were grown in RPMI-1640 containing 10% fetal calf
serum (FCS) and C100 cells were grown in 50% DMEM/
50% Ham’s F12 containing 10% FCS. COS7 cells were
grown in DMEM plus 10% FCS. Cell lines were trans-
fected with plasmids using Effectene (Qiagen, Courtaboeuf,
France) with conditions recommended by the manufacturer.
For AP-SEMA3F transfections in COS7 cells, the medium
was replaced 2 days after transfection by DMEM, containing
0.5% FCS or OPTIMEM media ( Invitrogen). The medium
was collected 4 days after transfection and applied to MCF7
and C100 cell cultures in serum-free medium for 14 hours.
SEMA3F concentration was estimated by alkaline phospha-
tase activity (GenHunter, Nashville, TN). Cell ruffling and
spreading were measured in cells grown in OPTIMEM for 15
hours before adding AP control media, AP-SEMA3F media,
or purified VEGF (Insight Biotechnology, Wembley, UK).
Quantitative RT-PCR
Total RNA and cDNA were prepared as described
previously [8 ]. We assessed levels of SEMA3F, NRP1,
NRP2, VEGF, and KDR transcription relative to G3PDH in
lung tumors by quantitative real - time RT-PCR carried out
using the GeneAmp 5700 (ABI) system with syber green
chemistry as described previously [8 ]. The PCR cycle at
which a particular sample reaches an arbitrary threshold
fluorescence level (C t ) is indicative of the input quantity of
that template. The PCR was carried out in 50 l reaction
volumes consisting of 1 PCR SYBR Green buffer, 0.25 M
primers, 200 M dNTPs, and 0.03 U/l AmpliTaq Gold
(Perkin-Elmer, Wellesley, MA). cDNA was amplified as
follows: 508C for 2 minutes, 958C for 10 minutes followed
by 40 cycles at 958C15 seconds, 608C1 minute.
SEMA3F, NRP1, NRP2, VEGF, KDR, and FLT-1 cDNA
were amplified with the following primers: SEMA3F for
50 AGCAGACCCAGGACGTGAG 30 and SEMA3F rev 50
AAGACCATGCGAATATCAGCC 30, giving a 112-bp prod-
uct; VEGF165 for 5
0 CAAGACAAGAAAATCCCTGTGG 30
and VEGF165 rev 5
0 CCTCGGCTTGTCACATCTG 30,
giving a 162-bp product; NRP2 for 50 GGATGGCATT-
CCACATGTTG 30 and NRP2 rev 50 ACCAGGTAGTAA-
CGCGCAGAG 30, giving a 152-bp product; NRP1 for
50ATCACGTGCAGCTCAAGTGG 30 and NRP1 rev 50 TCA-
TGCAGTGGGCAGAGTTC 30, giving a 167-bp product;
KDR for 50 TTCTCTTGATCTGCCCAGGC 30 and KDR rev 50
AGGCTCCAGTGTCATTTCCG 30, giving a 182-bp product;
FLT-1 for 50 ATGCCACCTCCATGTTTGATG and FLT-1
rev 50 GAGGCCTTGGGTTTGCTGTC 30, giving a 122-bp
product.
Immunostaining of Cell Lines
Immunostaining for SEMA3F was performed as
described [8], except that cells were finally exposed in the
dark to an Alexa488-conjugated goat antirabbit antibody
for 30 minutes (1:200) (Molecular Probes, Leiden, Nether-
lands). Cells were mounted using Vectashield (Vector,
Burlingame, CA). Immunostained samples were examined
using the blue line (488 nm) of a confocal microscope. For
NRP1 and NRP2 immunostaining, cell fixation was per-
formed in 1% paraformaldehyde for 15 minutes without
methanol fixation. For anti -NRP staining, we used a NRP1
rabbit polyclonal antibody (1:100) raised against amino
Table 1. Relative Expression of SEMA3F, NRP1, NRP2, VEGF, KDR, and
FLT -1 for MCF7 and C100 Cell (1000 ) Versus G3PDH.
Cell Lines SEMA3F NRP1 NRP2 VEGF KDR FLT -1
MCF7 27 4.2 0.0133 3 0 0.025
C100 0.017 1.5 62.5 3 0.04 0
Quantitative real - time RT -PCR was performed. The raw data were obtained
in terms of C t values, which refer to the PCR cycle number during exponential
amplification at which the product (measured in real time by SYBR green
fluorescence ) crosses an arbitrary threshold. To adjust for variations in the
amount of RNA, the C t values for each gene were normalized against the C t
values for the housekeeping gene, G3PDH ( i.e., C t =C tspecific geneC tG3PDH ).
While the resulting C t values are experimentally convenient, they are not
readily intuitive ( i.e., they reflect exponential amplification, and higher C t
values represent lower expression ). Instead, the results are displayed in
terms of the relative expression (1000 ) compared to G3PDH. Experiments
were done in triplicate and all the results are within 0.5 PCR cycle.
84 SEMA3F Inhibits Tumor Cell Spreading Nasarre et al.
Neoplasia . Vol. 5, No. 1, 2003
acids 583 to 856 of rat NRP1 (gift from Dr. A. L. Kolodkin,
Baltimore) [12] and an NRP2 rabbit polyclonal antibody
(1:50) raised against amino acids 560 to 858 of human
NRP2 (Santa Cruz Biotechnology, Santa Cruz, CA). Cells
were exposed in the dark to a second RRX-conjugated goat
anti - rabbit antibody diluted at 1:200 (Jackson Immunore-
search Laboratories, West Grove, PA). Immunostained
samples were examined using the yellow line (568 nm) of
the confocal microscope. NRP1 and NRP2 blocking experi-
ments were performed with a 2-hour preincubation with 10
g/ml anti -NRP2 polyclonal antibody (Santa Cruz Biotech-
nology) or /and 10 g/ml anti -NRP1 polyclonal antibody
(Oncogene, Darmstadt, Germany) as described [28].
Confocal Microscopy and Data Analysis
Labelled cells and those observed by transmission light
were examined by confocal scanning microscopy using a
BioRad MRC 1024 ES (BioRad, Hemel Hempstead, UK)
Figure 1. Immunostaining of endogenous SEMA3F and neuropilins in MCF7 and C100 cells. (A–C ) MCF7 cells stained for SEMA3F with a polyclonal antibody and
observed by laser scanning confocal microscopy ( LSCM). (A, B ) Horizontal optical section through the surface (A ), and the central part (B ) of the cell islet. (C )
Vertical optical section through the same cell islet obtained along the dotted line shown in (B ). The plain white line represents the plate surface. (D ) Horizontal optical
section obtained by LSCM on MCF7 cells labeled for NRP1 with a polyclonal antibody. (E, F ) C100 cells stained for NRP2 (E ) and NRP1 (F ) with a specific
polyclonal antibody and observed by means of LSCM.
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equipped with a 15-mW argon–krypton (Ar–Kr) gas laser.
The confocal unit was connected to an inverted microscope
(Olympus IX70; Olympus, Tokyo, Japan). Maximal reso-
lution was obtained with Olympus plan apo 60 water, 1.3
numerical aperture objective lens (x–y: 0.3 m; z: 0.45 m).
RRX fluorochromes were excited with the 568-nm yellow
line and the emission of fluorescence was collected through
a photomultiplier (PMT1) through a 605-nm band pass filter.
The Alexa488 fluorochrome was excited with the 488-nm
blue line and the emission of fluorescence was collected
through a photomultiplier (PMT2) through a 522-nm band
pass filter. Fluorescence signal collection, image construc-
tion, and scaling were performed through the control
software (Lasersharp 3.2; BioRad). Images and data
analysis were performed through the software Lasersharp
Processing (BioRad) and Origin 5.0 (Microcal Software,
Northampton, MA), respectively. Results were expressed as
mean±SEM. Statistical significance between the different
mean values was tested using Student’s t - test.
GST Pull -Down Assays
The GST-PAK-CRIB domain and GST-Rhotekin-RBD
were cloned into pGEX-2T fusion (gift of J. G. Collard,
Netherlands Cancer Institute, Amsterdam, The Netherlands)
[29]. The GST-PAK-CRIB and GST-Rhotekin-RBD
recombinant peptides were prepared in Escherichia coli
(BL21 strain) and purified using glutathione–sepharose
beads (Amersham Pharmacia Biotech, Bucks, UK).
A total of 5106 C100 and MCF7 cells were washed twice
in cold PBS and then lysed in 400 l of lysis buffer [50 mM
Tris–HCl, pH 7.4, 150 mMNaCl, 5 mMMgCl2, 0.05%NP-40
(wt /vol ), 1% DOC (wt /vol ), 1% Triton X-100, 0.1% SDS,
1.25 mM PMSF, 20 M leupeptin, 0.8 M aprotinin, 10 M
pepstatin ]. Total amount of protein in each lysate was
measured and diluted to 1 g/l. Lysates were repeatedly
passed through a syringe followed by centrifugation at
14,000g for 1 minute. The supernatant was mixed with
10 to 20 l of glutathione–sepharose beads corresponding
to 40 g of GST fusion protein and incubated at 48C
overnight. Bead-bound complexes were washed once in
lysis buffer and three times in the same buffer without DOC,
Triton X-100, and SDS. Samples were boiled in Laemmli
sample buffer and fractionated by a 12% SDS-PAGE
electrophoresis, followed by Western blotting. The presence
of RhoA was revealed using a polyclonal anti -RhoA antibody
(Santa Cruz Biotechnology). The presence of Rac1 was
revealed using a monoclonal anti -Rac1 antibody (Trans-
duction Laboratories, Lexington, KY). As second antibodies,
a sheep antimouse IgG, HRP- linked (Amersham Pharmacia
Biotech); or a donkey antirabbit IgG, HRP- linked (Amer-
sham Pharmacia Biotech) were used and blots were
revealed by ECL detection.
Time Lapse Microscopy
C100 cells were transfected with Rac1-GFP. The
medium was replaced 2 days after transfection by medium
without FCS for 14 hours. Time lapse microscopy was
started after AP-SEMA3F or AP media addition and
recorded every 30 seconds for 30 minutes. The GFP was
excited with the 488-nm blue line and the emission of
fluorescence was collected through a 522-nm band pass
filter.
Results
Expression of SEMA3F, Neuropilins, VEGF, KDR, and FLT-
1 in MCF7 and C100 Adenocarcinoma Cell Lines
The effects of SEMA3F were investigated in two breast
cancer cell lines, which exhibited different biologic pheno-
types. MCF7 cells, which grow in islets and exhibit numerous
intercellular contacts, provide a model of low metastatic
potential. In contrast, C100 cells are highly motile and
metastatic. Quantitative RT-PCR demonstrated that MCF7
cells express SEMA3F and NRP1 (Table 1), but barely
Figure 2. Western blot analysis of AP -SEMA3F expression. Media from
transfected AP (1 ) or AP -SEMA3F (2 ) COS7 cells were concentrated on
Microcon 10 (Amicon, Guyancourt, France ) and subjected to electrophoresis
on a 12% polyacrylamide gel. Immunodetection was performed with a
polyclonal AP antibody 1 /2500 (GenHunter ) in (A ) and loading controls
stained by Coomassie blue are shown in (B ).
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undetectable NRP2. Immunostaining of MCF7 cells con-
firmed these results. Using a specific polyclonal antibody
raised against SEMA3F [30], cytoplasmic SEMA3F was
detected. By laser confocal microscopy, the major distribu-
tion of SEMA3F was in near-membrane domains of cells
delineating the periphery of the islets (Figure 1, A and B ). In
a vertical section through the islets, SEMA3F is apically
located (Figure 1C ). Staining with anti -NRP polyclonal
antibodies showed that NRP1 was localized at the plasma
membrane of all cells within the islets (Figure 1D ), whereas
NRP2 staining was negative (not shown), consistent with the
RT-PCR results. The membranous pattern of staining in
MCF7 islets for SEMA3F was reminiscent of that obtained in
normal bronchial epithelial cells in situ, as well as in cultured
adenocarcinoma Calu-3 cells [8].
In contrast, the C100 cells contain very low levels of
SEMA3F transcripts, about 1600 times less than MCF7
(Table 1), and immunostaining with the polyclonal antibody
was negative (not shown). Quantitative RT-PCR showed
that C100 cells had high levels of NRP2 receptor mRNA, and
immunostaining against NRP2 showed a cytoplasmic vesic-
ular pattern together with a significant distribution of NRP2 at
the surface membrane (Figure 1E ). NRP1 was also
expressed in C100, but at levels that were approximately
one- third that in MCF7 (Table 1, Figure 1F ). Both C100 and
MCF7 expressed moderate levels of VEGF (compared to
various other cell lines not shown) and low to absent levels of
the VEGF receptor, KDR. In addition, FLT-1 was barely
detectable in MCF7 and absent in C100 cells.
Rapid Effects of Extracellular SEMA3F on Cell Morphology
Previous studies have shown that class 3 semaphorins
have a repulsive effect on developing axons and in COS7
cells transfected with neuropilins and plexins [25]. To
explore the effects of SEMA3F in MCF7 and C100 cells,
we transfected COS7 cells with alkaline phosphatase–
tagged SEMA3F (AP-SEMA3F), and the cultured super-
natant was used as a source of SEMA3F. As a negative
control, COS7 cells were transfected with the AP vector only.
This approach was first described by two groups [12,31],
and further widely used by others because bacterial or
Baculovirus-produced semaphorins are insoluble, presum-
ably due to their highly disulfide- linked nature. Secretion of
AP-SEMA3F was confirmed by Western blot (Figure 2) and
Figure 3. AP-SEMA3F reduced the ability of MCF7 cell islets and C100 cells
to expand. (A ) Total MCF7 islets areas were measured before and after
60 minutes of treatment at 378C, with COS7 cells culture media containing
0.5% FCS and secreted AP (white columns: control ) or AP -SEMA3F (black
columns ) at two different concentrations ( 60 and 170 ng /ml ). A volume of AP
media, equivalent to that of AP -SEMA3F media, is added for the control. The
percentage of increase in islet areas was calculated and reported on bar
graph. Error bars, SEM. (B ) Changes in cell surface area when MCF7 cells
are cultured for 15 minutes with control AP or AP -SEMA3F, 60 and 90 ng /ml,
with and without a blocking anti -NRP1 antibody. (C ) Mean C100 cells areas
were calculated before (white columns ) and after treatment for 30 minutes
( black columns ) with COS7 cells media containing 0.5% FCS and control AP
( left panel ) or AP -SEMA3F at 10 ng /ml (middle panel ). AP -SEMA3F was
added in the presence of an anti -NRP2 antibody ( right panel ). Error bars,
SEM.
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the enzymatic alkaline phosphatase activity was used to
determine the amount of SEMA3F protein applied to cells.
After a 60-minute incubation with control AP medium,
MCF7 cells were observed to spread and form membrane
ruffles and lamellipodia, which resulted in an increase in the
average surface area of cell islets and individual cells (Figure
3, A and B ). This cell spreading was significantly inhibited
after incubation with 60, 90, and 170 ng/ml AP-SEMA3F
(Figure 3, A and B ). The ruffling activity of MCF7 cells was
recorded by microcinematography (Figure 4A ). The number
of ruffles was increased over a 45-minute period by the AP
control medium, suggesting that COS7 cells secrete one or
more factors that positively affect membrane ruffling.
Alternatively, the effect of the AP control medium could be
due to the 0.5% serum from the transfected COS cells
because the MCF7 cells were placed in serum-free medium
before treatment (Figure 4B ). This background effect was
also dose-dependent (Figure 3A ). Nevertheless, membrane
ruffling was strongly inhibited by AP-SEMA3F (Figure 4B ).
When 100 ng/ml VEGF was added to control AP medium,
the ruffling activity was promoted (Figure 4C ). AP-SEMA3F
at 60 ng/ml was able to block the positive effect of VEGF
(Figure 4C ). These results are consistent with competing
actions of SEMA3A and VEGF on endothelial cells [16].
Figure 4.MCF7 cell ruffling is stimulated by VEGF but is inhibited by SEMA3F. MCF7 cells were grown with control AP or AP-SEMA3F and ruffling was recorded by
microcinematography (A ). Ruffles are shown by arrow heads and retraction by arrows. Mean number of ruffles per cell is shown in (B ). A total of 100 ng /ml VEGF
was tested on cell ruffling in the presence or absence of control AP or AP-SEMA3F (C ). Number of ruffling is expressed at time of 25 minutes. Error bars, SEM.
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Retraction of the cell body and extensions could be observed
in MCF7 cells that had separated from the islet. After
exposure to SEMA3F for 30 minutes, these cells rounded-up
and eventually detached from adjacent cells. This resulted in
an overall decrease in the number of cells within a micro-
scope field, whereas with control COS7 supernatant, the
number of cells increased from cell division.
Responses in C100 cells were more complex because of
morphologic heterogeneity. These cells could be divided in
three groups representing small round cells with few
extensions, spindle-shaped cells with neurite- like cell
processes, and extended cells with large lamellipodia.
Whereas the first and second groups of cells did not appear
to respond to SEMA3F, cell spreading was significantly
inhibited after 30 minutes by 10 ng/ml AP-SEMA3F in the
third subset of cells having an extended morphology. Thus,
the average cell surface area decreased as a result of
lamellipodia retraction (Figure 3C ), and other cells were
observed to round-up and detach from the substrate.
SEMA3F Signal Transduction
As MCF7 and C100 cells exhibited different patterns of
NRP1 and NRP2 expression, we tested antibodies for their
ability to block SEMA3F action. In MCF7, the SEMA3F
effects on cell spreading were inhibited by anti -NRP1
antibodies (Figure 3B ), whereas in C100 cells (Figure 3C ),
anti -NRP2 blocked SEMA3F inhibition of cell spreading
and anti -NRP1 had no effect. These results are consistent
with the levels of NRP1 and NRP2 expression in MCF7 and
C100 cells (Table 1) and also demonstrate that NRP1 can
function in SEMA3F signalling.
As neuropilin signal transduction has been shown to
involve small GTPases in neural cells, we looked for changes
in the amount of active GTP-bound Rac1 and RhoA using
GST fusion proteins expressing either the GST-PAK-CRIB
domain or GST-Rhotekin-RBD. In a pull -down experiment
using extracts of C100 and MCF7 cells treated with AP-
SEMA3F, we did not identify any difference in levels of GTP-
bound Rac1 and RhoA (Figure 5). Also, we did not find any
difference in the amount of total Rac1 and RhoA upon AP-
SEMA3F treatment. As this negative result might have been
due to insufficient sensitivity, we examined the subcellular
distribution of Rac1 using C100 cells transfected with Rac1-
GFP. Time lapse analysis by confocal laser scanning
microscopy showed that Rac1 was predominant at inter-
cellular junctions before the addition of AP-SEMA3F. Upon
Figure 5. Levels of Rac1 -GTP and RhoA -GTP were not affected by AP -SEMA3F. Levels of active Rac1 -GTP (A ) and RhoA -GTP (C ) were estimated by GST
pull - down assay in C100 and MCF7 cells after treatment with AP (1 ) or AP -SEMA3F (2 ). Total amount of total Rac1 (B ) and RhoA (D ) was determined by
Western blot after electrophoresis on a 12% SDS polyacrylamid gel, and a loading control is shown in (E ).
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addition of AP-SEMA3F, Rac1 was observed first at the
base of lamellipodia and subsequently at the membrane
(Figure 6A ). Isolated cells became spherical at the end of the
retraction process and were decorated with Rac1 around the
membrane (Figure 6B ). These results indicate that SEMA3F
induces changes in Rac1 activation, at least at a local level,
and that the presence of Rac1 at the membrane is
associated with the retraction.
Discussion
Semaphorins were initially identified on the basis of their
inhibition of nerve growth cone migration; however, they
clearly affect non-neural tissues. On the basis of its loca-
lization at 3p21.3, a region that undergoes frequent loss of
heterozygosity in lung tumors, and because of the activity of
genomic clones containing SEMA3F in suppressing tumor-
igenicity of mouse fibrosarcoma A9 cells [32], SEMA3F was
hypothesized to be a tumor-suppressor gene. Subsequent
studies demonstrated that SEMA3F protein expression was
decreased or absent in high-grade lung cancers [8 ]. These
studies also suggested, based on complementary staining
patterns, that SEMA3Fmight compete with VEGF for binding
to their common neuropilin receptors. More recent experi-
ments using single gene transfectants have confirmed that
SEMA3F has tumor-suppressor gene activity [10].
Our results demonstrate that SEMA3F and VEGF have
opposing actions on primary tumor cells. Whereas VEGF
promotes cell spreading and membrane ruffling, activities
associated with increased cell migration and metastasis,
SEMA3F inhibits these changes and is able to block the
effects of VEGF. During a brief treatment with AP-SEMA3F,
MCF7 cell spreading and lamellipodia extension were
inhibited and membrane ruffling was reduced. Even though
MCF7 cells do not express NRP2 (or express very little ),
they express NRP1 and responded to the cultured super-
natant of AP-SEMA3F expressing COS7 cells. These
effects were mediated by NRP1, as shown by the use of
an anti -NRP1 antibody, which blocked the activity. In
contrast, C100 cells express NRP2 at high levels, and
anti -NRP2 (but not anti -NRP1) antibodies were able to
block the SEMA3F effects. These results demonstrate that
both NRP1 and NRP2 are capable of binding and trans-
mitting SEMA3F signals. Although MCF7 cells express
SEMA3F, they still responded to exogenous SEMA3F. This
may simply represent a dosage effect in the presence of
excess NRP1 receptor. As noted, anti -SEMA3F staining
was detected predominantly at the periphery of the islets
whereas NRP1 staining was detected throughout. Also,
SEMA3F may have been in competition with VEGF present
in the cultured supernatant.
Initially considered as an endothelial -specific mitogen,
there is now evidence that VEGF stimulates nonendothelial
cell types. For example, VEGF stimulates osteoblast mig-
ration [33,34] and positively influences melanoma cell
migration in vitro through an integrin-dependent mecha-
nism [35]. We have not investigated whether SEMA3F
affects integrin activation. However, our findings do suggest
that SEMA3F affects cell adhesion as evidenced by the
separation of cells, their rounding-up, and subsequent
detachment from the substrate. These responses are likely
comparable to the effects seen in NP/plexin–transfected
COS7 cells following exposure to SEMA3A or SEMA3F [25].
In these cells, SEMA3F led to cytoskeleton perturbations
similar to those described in nerve growth cones. This
suggests that SEMA3F has a common action on different cell
types that may involve small GTP binding proteins like Rho
family GTPases because lamellipodia were generally af-
fected. Although we were unable to detect changes in total
GTP-bound Rac1 or Rho, we did detect changes in Rac1-
GFP localization. The Rho family of small GTPases is the
central regulator of cytoskeletal dynamics and controls
the organization of actin filaments and cellular morphology
[36]. In growth cones, SEMA3A (Collapsin) has been shown
to initiate clustering of neuropilin and plexin receptors. This
occurred in a CRMP-dependent manner and was Rac1-
Figure 6. Rac1 moved to the base of lamellipodia and later to the membrane upon AP -SEMA3F treatment. Time lapse analysis by confocal laser scanning
microscopy showed Rac -GFP localization in connected (A ) and in isolated C100 cells (B ) at time 0, 15, and 30 minutes after AP-SEMA3F addition.
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dependent ( for review, see Ref. [20] ). Similarly, plexin-A1,
a coreceptor for class 3 semaphorins, interacts not only with
Rnd1 but also with RhoD, and these GTPases have
antagonistic effects on the activity of plexin-A1 [37]. These
authors suggested that interaction of Rnd1 results in a
conformational change that ultimately activates downstream
signal transduction cascades, including Rac1, RhoA, LIM
kinase 1, and cofilin that mediate growth cone collapse [38].
Indeed, we demonstrated in epithelial tumor cells a clear
recruitment of Rac1 to retraction fibers upon AP-SEMA3F
treatment.
Finally, we have some additional observations regarding
the viability of the detached cells following SEMA3F
exposure. These cells were not able to reattach and the
number of cells decreased over time, suggesting that they
underwent apoptosis or anoikis. An apoptotic effect was
reported for SEMA3A in sensory neurons [39] and in neural
progenitors [40]. This apoptotic effect was shown to be
mediated by NRP1 and was antagonized by VEGF165 [40].
We also performed additional experiments showing that
C100 cells undergo apoptosis in response to transfected
SEMA3F as evidenced by annexin and propidium iodine
staining (data not shown).
In summary, we have shown that mammary adenocarci-
noma cells stimulated with SEMA3F lose lamellipodia
extensions and cell–cell contacts, and eventually detach
with subsequent apoptosis or anoikis. These effects can be
mediated by either NRP1 or NRP2 receptors and appear to
involve Rac1 redistribution.
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